JW (Cayman) Therapeutics Co. Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The Board comprises Executive Director Mr. Feng Tian; Non-executive Directors Dr. Cheng Liu (Chairman), Dr. Yiping James Li, Ms. Xing Gao, and Dr. Sungwon Song; and Independent Non-executive Directors Mr. Kin Cheong Kelvin Ho, Dr. Debra Yu, and Mr. Peng Kuan Chan. Committee memberships are as follows: Mr. Kin Cheong Kelvin Ho serves as Chairman of the Audit and Nomination Committees; Ms. Xing Gao and Mr. Peng Kuan Chan are members of the Audit Committee; Dr. Debra Yu is Chair of the Remuneration and Business Development and Strategy Committees and a member of the Nomination Committee; Dr. Sungwon Song and Mr. Peng Kuan Chan are members of the Remuneration Committee; Mr. Feng Tian and Ms. Xing Gao are members of the Nomination and Business Development and Strategy Committees, respectively.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JW Cayman Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251229-11968403), on December 29, 2025, and is solely responsible for the information contained therein.